Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.
Eap CB, Buclin T, Cucchia G, Zullino D, Hustert E, Bleiber G, Golay KP, Aubert AC, Baumann P, Telenti A, Kerb R.
Eap CB, et al. Among authors: cucchia g.
Eur J Clin Pharmacol. 2004 Jun;60(4):237-46. doi: 10.1007/s00228-004-0762-z. Epub 2004 Apr 28.
Eur J Clin Pharmacol. 2004.
PMID: 15114429
Clinical Trial.